“Now it is approved for lung cancer, gynecological cancers, biliary tract cancers – any type of cancer which expresses a target in the cancer cells called HER2-positive.” If your doctor has ...

Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer. All patients with breast cancer who may be candidates for antibody-drug ...

It’s natural to worry that your HER2-positive breast cancer might spread. Learn why this can happen and what signs to watch for.

While your HER2+ breast cancer treatment journey will be unique to you, this general timeline will give you an idea of what to expect.

Background: Variable rates of HER2 protein overexpression and gene amplification have been reported in advanced ovarian cancers (AOC). Trastuzumab, tested only as a single agent, has been shown to ...

These features mean that treating triple-positive breast cancer can involve using hormone therapy and drugs to target hormone receptors and HER2. Around 10% of all breast cancers are hormone ...

is a small molecule–inhibitor of HER2, meaning it slows the progression of cancers that carry the HER2 receptor. It has been approved by the FDA when combined with trastuzumab and capecitabine ...